Research Report University Hospital for clinical assessment 20110142

Abstract

A Multicenter, International, Randomized, Double-blind, Alendronate-controlled Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis

Keywords

• Osteoporosis
• Romosozumab